Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Bull Cancer ; 107(1S): S94-S103, 2020 Jan.
Artículo en Francés | MEDLINE | ID: mdl-31006487

RESUMEN

Since 2010 there has been an exponential increase of the number of transplants performed from related donors. The development of haploidentical transplants increases the resort to related-donation, which presents two main advantages: a less important financial cost and a faster availability of the graft. Standards for mandatory accreditation exist, but the adherence to these recommendations is not optimal: currently, different practices regarding the organizational modalities of care, recruitment criteria, qualification and follow-up of related donors have been observed among French transplant centers. The Francophone Society of Marrow Transplant and Cellular Therapy (SFGM-TC) has developed guidelines for the consent and the non-eligibility criteria for hematopoietic stem cell donors. A multidisciplinary group has devised a booklet as a medium to inform donors about hematopoietic cell donation and transplantation in a clear and accessible language. This paper provides recommendations on post-donation follow-up, taking into account both medical standards and organizational constraints of French centers. Some tools are proposed.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Donantes de Tejidos , Aloinjertos , Familia , Haplotipos/genética , Histocompatibilidad , Humanos , Consentimiento Informado , Comunicación Interdisciplinaria , Donadores Vivos , Obtención de Tejidos y Órganos/métodos , Obtención de Tejidos y Órganos/normas
2.
Bull Cancer ; 106(1S): S1-S9, 2019 Jan.
Artículo en Francés | MEDLINE | ID: mdl-30580913

RESUMEN

Allogeneic hematopoietic cell transplantation (HCT) is part of the standard of care for many hematological diseases. Over the last decades, significant advances in patient and donor selection, conditioning regimens as well as supportive care of patients undergoing allogeneic HCT leading to improved overall survival have been made. In view of many new treatment options in cellular and molecular targeted therapies, the place of allogeneic transplantation in therapy concepts must be reviewed. Most aspects of HCT are well standardized by national guidelines or laws as well as by certification labels such as FACT-JACIE. However, the requirements for human resources, construction and layout of a unit treating patients during the transplantation procedure and for different complications are not well defined. Here, we describe the process of planning a transplant unit in order to open a discussion that could lead to more precise guidelines in the field of personnel and infrastructural requirements for hospitals caring for people with severe immunosuppression.


Asunto(s)
Trasplante de Médula Ósea/normas , Ambiente de Instituciones de Salud/normas , Enfermedades Hematológicas/terapia , Trasplante de Células Madre Hematopoyéticas/normas , Aire/normas , Tratamiento Basado en Trasplante de Células y Tejidos/normas , Dieta Saludable/normas , Selección de Donante/normas , Francia , Personal de Salud/normas , Unidades Hospitalarias/normas , Humanos , Higiene , Terapia de Inmunosupresión/normas , Monitoreo Fisiológico/métodos , Ropa de Protección/normas , Sociedades Médicas , Esterilización/normas , Trasplante Homólogo/normas , Visitas a Pacientes
3.
Bull Cancer ; 104(12S): S71-S75, 2017 Dec.
Artículo en Francés | MEDLINE | ID: mdl-29126585

RESUMEN

Providing information to living donors is first and foremost a legal obligation as well as an ethical one, not to mention necessary to health care provision. It's been shown that quality of information concerning the procedure's practical aspects, scheduling of clinical tests and examinations, withdrawing stem cells for the donation, post-donation symptoms, and support provided by healthcare teams, directly impacts the donor's quality of experience. Taking this into consideration our group decided it was essential to create an informational support for donors in the form of a booklet to be provided in different hematopoietic stem cell transplant centers across France. In September 2016 in Lille, France, the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) organized the 7th allergenic hematopoietic stem cell transplantation clinical practices harmonization workshops. As part of these workshops, our group worked collectively to develop a basis of indispensable information to be included in the booklet and presented using clear and accessible language.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Donadores Vivos/educación , Folletos , Francia , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Trasplante de Células Madre Hematopoyéticas/ética , Trasplante de Células Madre Hematopoyéticas/legislación & jurisprudencia , Humanos , Sociedades Médicas
4.
Bull Cancer ; 103(11S): S198-S200, 2016 Nov.
Artículo en Francés | MEDLINE | ID: mdl-27842861

RESUMEN

Within the context of the SFGM-TC's 6th workshop series on the harmonization of clinical practices, our workshop proposes a standardization of the informed consent process for hematopoietic stem cell donors and recipients leading up to an autologous or allogenic transplantation. All informed consent was for bone marrow or peripheral stem cell donors, and mononuclear/lymphocyte donors according to usual procedures. The informed consent for autologous and allogenic related or unrelated adults and pediatric transplantation patients have been included. A first step has been conducted for collecting in advance the informed consent forms used routinely in all francophone transplantation centers. In a second step, a comprehensive version has been re-written by a multidisciplinary team. For the purposes of understanding the risks and advantages, language has been carefully considered and streamlined. In the third step, texts were sent to stem cell transplantation experts, experts at the French biomedical agency (agence de la biomédecine [ABM]), law specialists, members of the ethical committee of the French society of hematology and several transplant recipients to be edited and proofread.


Asunto(s)
Conferencias de Consenso como Asunto , Formularios de Consentimiento/normas , Trasplante de Células Madre Hematopoyéticas/normas , Sociedades Médicas/normas , Donantes de Tejidos , Adulto , Niño , Familia , Francia , Células Madre Hematopoyéticas , Humanos , Linfocitos , Proyectos Piloto , Estudios de Validación como Asunto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA